Sensyne Health (LON:SENS) Hits New 12-Month Low at $120.00

Shares of Sensyne Health PLC (LON:SENS) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 120 ($1.57) and last traded at GBX 123.50 ($1.61), with a volume of 14854 shares traded. The stock had previously closed at GBX 123.50 ($1.61).

Separately, Peel Hunt reaffirmed a “buy” rating on shares of Sensyne Health in a research note on Wednesday.

The company has a debt-to-equity ratio of 1.60, a quick ratio of 13.22 and a current ratio of 13.29. The company has a market capitalization of $158.64 million and a price-to-earnings ratio of 6.78.

COPYRIGHT VIOLATION NOTICE: “Sensyne Health (LON:SENS) Hits New 12-Month Low at $120.00” was published by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at

Sensyne Health Company Profile (LON:SENS)

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts.

Recommended Story: Treasury Bonds

Receive News & Ratings for Sensyne Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensyne Health and related companies with's FREE daily email newsletter.